AU
Aura Biosciences, Inc.
AURA · NASDAQ
$6.99 -2.10% (-$0.15)
1M -9.81%
Market Cap $723.0M
P/E Ratio -
Div. Yield -
ROE 73.18%
Bulios Fair Price
$4.18
40.2% downside
Trenutna cena
$6.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AURA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
80 /100
Cheap P/B 2.29x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 11.21%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 41.63%
ROE 73.18%
ROA 37.63%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 16.82x
Int. coverage N/A
Stability
61 /100
Moderate Beta 0.40x
EPS volatility 5.21%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AURA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Natalie C. Holles
Employees
113
Headquarters
Boston
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report